Anzeige
Mehr »
Login
Freitag, 04.04.2025 Börsentäglich über 12.000 News von 693 internationalen Medien
Warum Almonty Industries zum Schlüsselplayer für NATO-Staaten wird
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1JLYP | ISIN: KYG211081248 | Ticker-Symbol: 2M7C
Frankfurt
04.04.25
08:05 Uhr
0,940 Euro
0,000
0,00 %
Branche
Gesundheitswesen
Aktienmarkt
ASIEN
1-Jahres-Chart
CHINA MEDICAL SYSTEM HOLDINGS LTD Chart 1 Jahr
5-Tage-Chart
CHINA MEDICAL SYSTEM HOLDINGS LTD 5-Tage-Chart
RealtimeGeldBriefZeit
0,9251,00008:31
0,9400,97507:30

Aktuelle News zur CHINA MEDICAL SYSTEM Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiCMS (00867): FORM OF PROXY-
MiCMS (00867): NOTICE OF ANNUAL GENERAL MEETING-
MiCMS (00867): PROPOSALS FOR (1) RE-ELECTION OF THE RETIRING DIRECTORS (2) DECLARATION OF FINAL DIVIDEND (3) GENERAL MANDATES TO ISSUE SHARES AND TO REPURCHASE ...-
MiCMS (00867): ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2024-
CHINA MEDICAL SYSTEM Aktie jetzt für 0€ handeln
MiCMS (00867): ANNUAL REPORT 2024-
21.03.China Medical System Holdings Ltd. (00867) Released its 2024 Annual Results: Focusing on Innovation and Specialty Breakthroughs to Reshape Growth Momentum219SHENZHEN, CHINA, March 21, 2025 (GLOBE NEWSWIRE) -- On March 17, China Medical System Holdings Limited ("CMS" or the "Company") released its 2024 annual results. The Company recorded a turnover of...
► Artikel lesen
17.03.CMS (00867): FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 20241
17.03.CMS (00867): ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2024 AND PROPOSED AMENDMENTS TO THE EXISTING MEMORANDUM AND ARTICLES OF ASSOCIATION ...-
12.03.CMS (00867): VOLUNTARY AND BUSINESS UPDATE ANNOUNCEMENT APPROVAL OF DRUG CLINICAL TRIALS FOR INNOVATIVE DRUG CARDIAC MYOSIN INHIBITOR CMS-D003-
05.03.CMS (00867): NOTICE OF BOARD MEETING-
14.02.China Medical System Holdings Ltd. (867.HK) is Included in the S&P Global Sustainability Yearbook 20255
24.01.China Medical System Holdings Ltd. (00867) Obtained Class 1 Innovative Drug Long-acting Anti-IL-4Ra Monoclonal Antibody MG-K10165SHENZHEN, CHINA, Jan. 24, 2025 (GLOBE NEWSWIRE) -- China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or "CMS") is pleased to announce that on 24 January...
► Artikel lesen
24.01.CMS (00867): VOLUNTARY AND BUSINESS UPDATE ANNOUNCEMENT SIGNING A COLLABORATION AGREEMENT FOR CLASS 1 INNOVATIVE DRUG MG-K10 HUMANIZED MONOCLONAL ANTIBODY ...1
08.01.China Medical System Holdings Ltd. (00867) Obtained New Drug ZUNVEYL for the Treatment of Mild-to-Moderate Dementia of the Alzheimer's Type113SHENZHEN, CHINA, Jan. 08, 2025 (GLOBE NEWSWIRE) -- China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or "CMS") is pleased to announce that on 8 January...
► Artikel lesen
08.01.CMS (00867): VOLUNTARY AND BUSINESS UPDATE ANNOUNCEMENT SIGNING A LICENSE, COLLABORATION AND DISTRIBUTION AGREEMENT OF IMPROVED NEW DRUG ZUNVEYL FOR THE ...-
09.12.24China Medical System Holdings Ltd.: First Prescriptions for Innovative Drug Lumeblue Issued in China185SHENZHEN, CHINA, Dec. 08, 2024 (GLOBE NEWSWIRE) -- On 6 December, China Medical System Holdings Limited ("CMS" or the "Group") is pleased to announce that the first prescriptions for the innovative...
► Artikel lesen
02.12.24China Medical System Holdings Ltd. Gained Exclusive Commercialization Right of Class 1 Innovative Drug Targeting Gout and Hyperuricemia192SHENZHEN, CHINA, Dec. 02, 2024 (GLOBE NEWSWIRE) -- China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or "CMS") is pleased to announce that on 2 December...
► Artikel lesen
02.12.24CMS (00867): VOLUNTARY AND BUSINESS UPDATE ANNOUNCEMENT GAINING EXCLUSIVE COMMERCIALIZATION RIGHT OF CLASS 1 INNOVATIVE DRUG FOR THE TREATMENT OF GOUT ...1
27.11.24CMS (00867): VOLUNTARY AND BUSINESS UPDATE ANNOUNCEMENT APPROVAL OF DRUG CLINICAL TRIALS FOR INNOVATIVE DRUG DUAL AGONIST OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR/GLUCAGON ...-
05.11.24CMS (00867): VOLUNTARY AND BUSINESS UPDATE ANNOUNCEMENT NEW DRUG APPLICATION OF RUXOLITINIB PHOSPHATE CREAM FOR VITILIGO APPROVED IN HONG KONG-
Seite:  Weiter >>
29 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1